
AzurRx BioPharma, Inc. (AZRX) Stock Suffers Following Upsizing of Previously Announced Public Offering
AzurRx BioPharma, Inc. (AZRX) stock prices were down 19.66% as of the market closing on July 23rd, 2021, bringing the price per share down to
Home » AZRX
AzurRx BioPharma, Inc. (AZRX) stock prices were down 19.66% as of the market closing on July 23rd, 2021, bringing the price per share down to
AzurRx BioPharma Inc. (AZRX) stock declined 16.03% in after-hours on Thursday, July 22, 2021. The stock closed at $0.59 per share. Before that in the
AzurRx BioPharma Inc. (AZRX) stock declined by 3.92% at the last trading close whereas the AZRX stock gains by 2.04% in the pre-market trading after
Bionano Genomics Inc. (BNGO) stock soared 13.81% to $2.39 in the pre-market trading following an announcement from the firm that Nasdaq has granted the Company
AzurRx Biopharma Inc [NASDAQ:AZRX] has been trading on a bullish channel since May. For the last few days, the stock has gained upside momentum and
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.